PT Anugerah Pharmindo Lestari (APL), a Zuellig Pharma Company — a leading healthcare services company in Indonesia — has been serving Indonesia’s healthcare industry since 1985. With a strong commitment to enhancing access to healthcare services, APL is trusted by a diverse range of stakeholders, including renowned global pharmaceutical companies.

This trust empowers more than 2,500 dedicated employees to deliver best in-class distribution, commercial, and clinical trial support services nationwide. Today, APL reaches over 60,000 healthcare facilities across 434 cities, supported by a National Distribution Center, a network of pharma-grade branches and warehouses, and strategic partners across the country.

APL continues to advance digital transformation to strengthen connectivity within Indonesia’s healthcare ecosystem. Guided by our commitment to sustainability, we actively invest in creating a healthier future for Asia, focusing on four priorities: advancing healthcare outcomes, developing talent, preserving the environment, and upholding integrity. As we grow, we remain steadfast in expanding our capabilities to meet the evolving healthcare needs of communities and to support the transformation of Indonesia’s healthcare system.